Category Archives: U.S. Policy and Funding

With vaccine rates stalled, measles outbreaks deliver deadly, debilitating impacts worldwide

By on .

DRC, Liberia, Madagascar, Somalia and Ukraine account for nearly half of global measles cases Measles incidence increased in five regions around the world between 2016 and 2018, while deaths from disease rose from 2017 to 2018, data released jointly by the U.S. Centers for Disease Control and Prevention and the World Health Organization today show. […]

Lot quality assurance sampling saves time, money while providing valuable information on HIV services

By on .

The following is a guest post by David Boone, Ph.D., of MEASURE Evaluation Most HIV monitoring and evaluation folks are familiar with the challenges of keeping track of the number of patients currently on treatment, and the data quality problems that result from poor record keeping. Patients need to be followed perpetually, and they come […]

What we’re reading: Harm in immigrant detention facilities and what needs to happen when children die in U.S. custody

By on .

A natural death: The political battlefield of infections and migrant children’s bodies – Tracing the events surrounding the death of eight-year-old Felipe Alonso Gomez in U.S. custody, Dr. Mark Travassos makes a compelling case for advocacy and action to expose and end harrowing violations of health and human rights in immigrant detention facilities. From the […]

Integrating services means thinking outside silos

By on .

The following is a guest post by Jay Gribble of Health Policy Plus and Alyson Lipsky of RTI and Health Policy Plus Donors, implementers, and governments alike have pursued health service delivery integration to achieve cost-efficient health outcomes. Yet, often driven by the needs of a specific health issue, programs are put into silos without […]

PLACE supports focus on local HIV drivers, answers

By on .

The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation The Priorities for Local AIDS Control Efforts  — PLACE –method aims to improve our understanding of the drivers of local HIV epidemics, identify gaps in services available to those most likely to acquire and transmit HIV, and provide evidence that can support […]

A “Big IDea” takes infectious disease education and advocacy to Washington

By on .

A day before the opening of the  joint annual meeting of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, the HIV Medical Association, and the Pediatric Infectious Diseases Society in Washington, DC, about 70 infectious diseases and HIV specialists, researchers and clinicians came to town for a day of educating their […]

Country’s effort toward historic HCV elimination goal highlights challenges

By on .

A small Eastern European country with limited resources and a high prevalence of hepatitis C, Georgia had factors in its favor in 2015, when it launched a historic effort to eliminate the virus. It had demonstrated both political will and technical capacities with an approach to universal access to health services that had led to […]

What we’re reading: An Ebola analysis and a Senate spending bill

By on .

The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages of an effective vaccine and now proven treatments the 10th Ebola outbreak in the Democratic Republic of Congo continues to defy control and threaten the region. Continued political and […]

Toolkit supports data gathering to aid children often overlooked

By on .

The following is a guest post by Jacqueline Hellen and Lisa Parker of MEASURE Evaluation While programs in low- and middle-income countries seek to support children living outside traditional households or in adverse situations that expose them to HIV, violence, trafficking, or other risks to their well-being, programs HIV and social service programs in resource-limited […]

Treatment rationing, other structural barriers stand in the way of stopping spread of hepatitis C among people living with HIV, study finds

By on .

When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of liver damage — to make the medicines universally accessible, the numbers of people who accessed the treatment nearly doubled, a study reported in Clinical Infectious Diseases found. New initiation […]